ATYR1940 Study Extension Aims to Define Safety, PK, and Activity in Muscular Dystrophy
Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study Extension
Abstract
The ATYR1940 study extension seeks to characterize the safety, tolerability, pharmacokinetics, and activity of the compound in adult muscular dystrophy patients.